NCT06305767 2026-01-13INTerpath-005Merck Sharp & Dohme LLCPhase 1/2 Active not recruiting230 enrolled
NCT03978624 2025-10-15Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder CancerUNC Lineberger Comprehensive Cancer CenterPhase 2 Active not recruiting20 enrolled 11 charts
NCT03924895 2025-08-28KEYNOTE-905Merck Sharp & Dohme LLCPhase 3 Active not recruiting595 enrolled 3 FDA
NCT00938145 2025-04-113 Tesla MRI in Patients With Bladder CancerUniversity of CincinnatiPhase NA Active not recruiting98 enrolled